GlassScriptPhysician profile
Monica C Bruna
NPI 1154805596
$782.00
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $361 · 2022: $331 · 2023: $89.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $89.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $89.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $133.01 | 2021-2023 | Xeomin |
| Astrazeneca Pharmaceuticals LP | $67.24 | 2021-2022 | |
| Novo Nordisk INC | $60.67 | 2021-2023 | |
| Abbvie INC. | $45.08 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $42.45 | 2021-2022 | |
| Lilly USA, LLC | $38.74 | 2021-2022 | |
| Daiichi Sankyo INC. | $34.45 | 2021 | |
| Nestle Healthcare Nutrition INC. | $31.56 | 2021-2022 | |
| Amgen INC. | $29.96 | 2022 | |
| Amarin Pharma, INC. | $27.36 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.50 | 2022 | |
| Urovant Sciences INC | $21.40 | 2022 | |
| Genentech USA, INC. | $21.39 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.43 | 2022 | |
| Edwards Lifesciences Corporation | $19.40 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $17.93 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.36 | 2022 | |
| Redhill Biopharma INC. | $15.78 | 2022 | |
| Cranial Technologies, INC | $15.32 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.52 | 2023 | Seglentis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.24 | 2022 | |
| Sumitomo Pharma America, INC. | $12.65 | 2023 | Gemtesa |
| Glaxosmithkline, LLC. | $12.61 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.00 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $11.97 | 2021 | |
| Astellas Pharma US INC | $11.52 | 2021 | |
| Organon LLC | $9.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Bruna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.